Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study

被引:3
|
作者
Hu, Ya [1 ,2 ]
Huang, Ziyuan [1 ,2 ]
Cao, Qianqian [1 ]
Chen, Bo [1 ,2 ]
Xu, Shungang [1 ,2 ]
Qiu, Wenxian [1 ,2 ]
You, Xiaohan [1 ,2 ]
Zhang, Ji [1 ,2 ]
Chen, Chaosheng [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affifiliated Hosp 1, Dept Nephrol, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Inst Chron Kidney Dis, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Dept Nephrol, Affifiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
关键词
IgA nephropathy; nephrotic syndrome; proteinuria; OXFORD CLASSIFICATION;
D O I
10.1080/0886022X.2023.2267138
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Both primary IgA nephropathy (IgAN) with and without nephrotic syndrome (NS) can present massive proteinuria (24-h urinary protein >= 3.5 g/d). The clinical significance of massive proteinuria may be different in the two entities and needs further research.Methods: Data of 1870 patients with biopsy-proven IgAN in our hospital from January 2011 to December 2022 was retrospectively reviewed. A total of 242 IgAN patients with massive proteinuria were enrolled. Patients who presented with nephrotic syndrome at renal biopsy were included in the IgAN with NS cohort (IgAN-NS). The IgAN with nephrotic-range proteinuria cohort (IgAN-NR) consisted of 1:1 matched cases from the remaining according to age, gender, estimated glomerular filtration rate (eGFR) at baseline, and follow-up time. The clinical and pathological characteristics between the two cohorts were analyzed.Results: The IgAN-NS had a significantly higher proteinuria level than the IgAN-NR (p < .001). Cluster analysis revealed that proteinuria was associated with lipids in IgAN-NS, while it was associated with inflammatory indicators in IgAN-NR. When the complete remission of proteinuria (CR) was not achieved, the Kaplan-Meier analysis showed the prognosis of IgAN-NS was significantly worse than that of IgAN-NR (p = .04). Then, our GLMM model and line chart showed that the serum albumin level of the IgAN-NR was always evidently higher than that of the IgAN-NS while the significant difference in urinary albumin/creatinine ratio between the two cohorts gradually disappeared during the short-term follow-up (1 year). Moreover, the Cox regression analysis showed that the increased serum albumin was an independent protective factor for the poor outcomes (eGFR decreased from the baseline >= 30% continuously or reached end-stage renal disease [ESRD]).Conclusion: The IgAN-NS had poorer clinicopathologic manifestation than IgAN-NR, including severer massive proteinuria. When the CR was not achieved, the prognosis of IgAN-NS was inferior to that of the IgAN-NR.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection
    Živile Riispere
    Anne Kuudeberg
    Elviira Seppet
    Kristin Sepp
    Madis Ilmoja
    Merike Luman
    Külli Kõlvald
    Asta Auerbach
    Mai Ots-Rosenberg
    BMC Nephrology, 18
  • [42] Spectrum of Nephrotic Syndrome in Adults: Clinicopathological Study from a Single Center in India
    Golay, Vishal
    Trivedi, Mayuri
    Kurien, Anila Abraham
    Sarkar, Dipankar
    Roychowdhary, Arpita
    Pandey, Rajendra
    RENAL FAILURE, 2013, 35 (04) : 487 - 491
  • [43] Acute kidney injury in children with nephrotic syndrome: a single-center study
    Sharma, Manjuri
    Mahanta, Arunima
    Barman, Anup Kumar
    Mahanta, P. J.
    CLINICAL KIDNEY JOURNAL, 2018, 11 (05) : 655 - 658
  • [44] Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Holzman, Lawrence B.
    Ojo, Akinlolu O.
    Song, Peter X. K.
    Barisoni, Laura
    Sampson, Matthew G.
    Kopp, Jeffrey B.
    Lemley, Kevin V.
    Nelson, Peter J.
    Lienczewski, Chrysta C.
    Adler, Sharon G.
    Appel, Gerald B.
    Cattran, Daniel C.
    Choi, Michael J.
    Contreras, Gabriel
    Dell, Katherine M.
    Fervenza, Fernando C.
    Gibson, Keisha L.
    Greenbaum, Larry A.
    Hernandez, Joel D.
    Hewitt, Stephen M.
    Hingorani, Sangeeta R.
    Hladunewich, Michelle
    Hogan, Marie C.
    Hogan, Susan L.
    Kaskel, Frederick J.
    Lieske, John C.
    Meyers, Kevin E. C.
    Nachman, Patrick H.
    Nast, Cynthia C.
    Neu, Alicia M.
    Reich, Heather N.
    Sedor, John R.
    Sethna, Christine B.
    Trachtman, Howard
    Tuttle, Katherine R.
    Zhdanova, Olga
    Zilleruelo, Gaston E.
    Kretzler, Matthias
    KIDNEY INTERNATIONAL, 2013, 83 (04) : 749 - 756
  • [45] Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study
    Yoshinori Sato
    Hiroyasu Tsukaguchi
    Koichiro Higasa
    Naoto Kawata
    Kiyoko Inui
    Tran Nguyen Truc Linh
    Tran Thuy Huong Quynh
    Inoue Yoshihiko
    Fumihiko Koiwa
    Ashio Yoshimura
    BMC Nephrology, 22
  • [46] Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study
    Sato, Yoshinori
    Tsukaguchi, Hiroyasu
    Higasa, Koichiro
    Kawata, Naoto
    Inui, Kiyoko
    Tran Nguyen Truc Linh
    Tran Thuy Huong Quynh
    Yoshihiko, Inoue
    Koiwa, Fumihiko
    Yoshimura, Ashio
    BMC NEPHROLOGY, 2021, 22 (01)
  • [47] Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING study
    Guo, Yingman
    Shi, Sufang
    Zhao, Jinghong
    Wang, Caili
    Liu, Zhangsuo
    Fu, Shuxia
    Chen, Nan
    Li, Guisen
    Wang, Lihua
    Ni, Zhaohui
    Zhang, Haitao
    Lai, Lingyun
    Lv, Jicheng
    Zhang, Hong
    RENAL FAILURE, 2024, 46 (02)
  • [48] Comparison of clinicopathological features and prognosis between IgA nephropathy and purpura nephritis in adults with diffuse endocapillary proliferation: a single-center cohort study
    Yu, Jin
    Ni, Xiaoqiu
    Ni, Jun
    Jiang, Fei
    Yu, Dongrong
    Zhou, Liusha
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (03) : 795 - 804
  • [49] Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort
    Bellur, Shubha S.
    Roberts, Ian S. D.
    Troyanov, Stephan
    Royal, Virginie
    Coppo, Rosanna
    Cook, H. Terence
    Cattran, Daniel
    Arce Terroba, Yolanda
    Asunis, Anna Maria
    Bajema, Ingeborg
    Bertoni, Elisabetta
    Bruijn, Jan A.
    Cannata-Ortiz, Pablo
    Casartelli, Donatella
    Di Palma, Anna Maria
    Ferrario, Franco
    Fortunato, Mirella
    Furci, Luciana
    Gakiopoulou, Hariklia
    Ljubanovic, Danica Galesic
    Giannakakis, Konstantinos
    Goma, Montserrat
    Groene, Hermann-Josef
    Gutierrez, Eduardo
    Haider, S. Asma
    Honsova, Eva
    Ioachim, Elli
    Karkoszka, Henryk
    Kipgen, David
    Maldyk, Jagoda
    Mazzucco, Gianna
    Orhan, Diclehan
    Ozluk, Yasemin
    Pantzaki, Afroditi
    Perkowska-Ptasinska, Agnieszka
    Riispere, Zivili
    Soderberg, Magnus P.
    Steenbergen, Eric
    Stoppacciaro, Antonella
    Von Feilitzen, Birgitta Sundelin
    Tardanico, Regina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (10) : 1681 - 1690
  • [50] The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study
    Takaya Handa
    Hiroko Kakita
    Yu Tateishi
    Tomomi Endo
    Hiroyuki Suzuki
    Toshiro Katayama
    Tatsuo Tsukamoto
    Eri Muso
    Clinical and Experimental Nephrology, 2018, 22 : 1116 - 1127